Prevention of calcium and vitamin D deficiency in osteoporosis: possibility of using combined drugs Osteomed, Osteomed Forte, Osteo-Vit D3

DOI: https://doi.org/10.29296/25877305-2023-03-18
Issue: 
3
Year: 
2023

Professor D. Dedov(1), MD; Professor A. Ivanov(1), MD; E. Mikhailova(2); L. Boytsova(2)
1-Tver State Medical University
2-Tver State Technical University

Objective. To analyse literature data reflecting the issue of prevention of calcium and vitamin D deficiency in osteoporosis. Material and methods. Analysis of 47 Russian and foreign publications on prevention of calcium and vitamin D deficiency in osteoporosis was carried out. Results and discussion. The role of vitamin D in maintenance of calcium homeostasis and bone metabolism has been shown. Lack of vitamin D is associated with the development of osteomalacia and osteoporosis in adults and rickets in children. It was noted that hypovitaminosis D was recognised as a worldwide pandemic. It was acknowledged that there was a need to develop dietary recommendations, supplementary intake of vitamin D to prevent, among other things, bone diseases in most countries of the world. The results of the study of the Russian drugs Osteomed, Osteomed Forte, Osteo-Vit D3 (Parapharm, Russia) were presented. Conclusions. Thus, combined preparations of Ca and vitamin D were of great importance for prevention and complex treatment of osteoporosis, for the compensation of calcium deficiency in adolescence, elderly, during pregnancy, lactation and after menopause. Combined calcium and vitamin D supplementation was more effective than monotherapy in slowing bone loss, reducing the risk of fractures, strengthening the skeletal musculature and reducing the probability of falls, disability and death, but promotes calcification of soft tissues and blood vessels. At the same time, the only osteoprotectors without the risk of calcification of blood vessels and soft tissue, as well as the development of atherosclerosis, to date recognized by the Russian line of drugs "Osteomed. The safety of this group of dietary supplements, including their use in the treatment of bone pathologies in children and adolescents, is ensured by the presence of a unique HDBA organic complex. This component, by correcting the hormonal status and maintaining an optimal level of androgens within the age norm, has an anabolic effect, stimulating the birth of new bone cells. It is activation of reparative processes at the cellular level that enables to realize the effect of targeted delivery of calcium into bone tissue.

Keywords: 
therapy
calcium
vitamin D
osteoporosis
prevention
drugs
Osteomed
Osteomed Forte
Osteo-Vit D3
Parapharm



References: 
  1. Мельниченко Г.А., Белая Ж.Е., Рожинская Л.Я. и др. Федеральные клинические рекомендации по диагностике, лечению и профилактике остеопороза. Проблемы Эндокринологии. 2017; 63 (6): 392–426 [Mel'nichenko G.A., Belaya Z.E., Rozhinskaya L.Y. et al. Russian federal clinical guidelines on the diagnostics, treatment, and prevention of osteoporosis. Problems of Endocrinology. 2017; 63 (6): 392–426 (in Russ.)]. DOI: 10.14341/probl2017636392-426
  2. Струков В.И., Елистратов Д.Г., Вихрев Д.В. и др. Персонифицированный подход к терапии коморбидного остеопороза в клинической практике. Врач. 2022; 33 (6): 20–5 [Strukov V., Elistratov D., Vikhrev D. et al. A personalized approach to therapy for comorbid osteoporosis in clinical practice. Vrach. 2022; 33 (6): 20–5 (in Russ.)]. DOI: 10.29296/25877305-2022-06-03
  3. Джоунс О., Струков В., Кислов А. и др. Коморбидный остеопороз: проблемы и новые возможности диагностики (ч. 1). Врач. 2017; 10: 23–7 [Jones O., Strukov V., Kislov A. et al. Comorbid osteoporosis: challenges and new diagnostic opportunities (Part 1). Vrach. 2017; 10: 23–7 (in Russ.)].
  4. Rachner T.D., Khosla S., Hofbauer L.C. Osteoporosis: now and the future. Lancet. 2011; 377 (9773): 1276–87. DOI: 10.1016/S0140-6736(10)62349-5
  5. Яриков А.В., Денисов А.А., Масевнин С.В. и др. Остеопороз в практике вертебролога. Врач. 2020; 31 (3): 11–8 [Yarikov A., Denisov A., Masevnin S. et al. Osteoporosis in the practice of a vertebrologist. Vrach. 2020; 31 (3): 11–8 (in Russ.)]. DOI: 10.29296/25877305-2020-03-02
  6. Джоунс О., Струков В., Кислов А. и др. Коморбидный остеопороз: проблемы и новые возможности терапии (ч. 2). Врач. 2017; 11: 25–29 [Jones O., Strukov V., Kislov A. et al. Comorbid osteoporosis: challenges and new diagnostic opportunities (Part 2). Vrach. 2017; 11: 25–9 (in Russ.)].
  7. Яриков А.В., Смирнов И.И., Павлинов С.Е. и др. Остеопороз позвоночника: эпидемиология, современные методы диагностики и принципы лечения. Врач. 2020; 31 (11): 21–8 [Yarikov A., Smirnov I., Pavlinov S. et al. Osteoporosis of the vertebral column: epidemiology, current diagnostic methods, and treatment principles. Vrach. 2020; 31 (11): 21–8 (in Russ.)]. DOI: 10.29296/25877305-2020-11-04
  8. Перльмуттер О.А., Яриков А.В., Лобанов И.А. и др. Остеопороз: текущее состояние проблемы, современные методы нейровизуализации и принципы лечения. Врач. 2020; 31 (12): 52–60 [Perlmutter O., Yarikov A., Lobanov I. et al. Osteoporosis: the current state of the problem, modern neuroimaging techniques, and treatment principles. Vrach. 2020; 31 (12): 52–60 (in Russ.)]. DOI: 10.29296/25877305-2020-12-11
  9. Павлова Т., Башук И. Клинико-морфологические особенности дегенеративных изменений костной ткани на фоне остеопороза в возрастном аспекте. Врач. 2019; 30 (6): 47–50 [Pavlova T., Bashuk I. Clinical and morphological features of degenerative changes in bone tissue with osteoporosis in age aspects. Vrach. 2019; 30 (6): 47–50 (in Russ.)]. DOI: 10.29296/25877305-2019-06-11
  10. Марченкова Л.А., Макарова Е.В. Преимущества комбинации кальция и витамина D в профилактике и лечении остеопороза: ренессанс парадигмы. Профилактическая медицина. 2017; 20 (4): 57 62 [Marchenkova LA, Makarova EV. Benefits of combined calcium and vitamin D in the prevention and treatment of osteoporosis: Renaissance of the paradigm. Profilakticheskaya Meditsina. 2017; 20 (4): 57–62 (in Russ.)]. DOI: 10.17116/profmed201720457-62
  11. Capozzi A., Scambia G., Lello S. Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health. Maturitas. 2020; 140: 55–63. DOI: 10.1016/j.maturitas.2020.05.020
  12. Струков В., Кислов А., Елистратов Д. и др. Персонифицированный подход в терапии остеопороза у пожилых. Врач. 2015; 6: 51–3 [Strukov V., Kislov A., Elistratov D. et al. Personified approach in the therapy of osteoporosis in elderly patients. Vrach. 2015; 6: 51–3 (in Russ.)].
  13. Emkey R.D., Emkey G.R. Calcium metabolism and correcting calcium deficiencies. Endocrinol Metab Clin North Am. 2012; 41 (3): 527–56. DOI: 10.1016/j.ecl.2012.04.019
  14. Reid I.R. Therapy of osteoporosis: calcium, vitamin D, and exercise. Am J Med Sci. 1996; 312 (6): 278–86. DOI: 10.1097/00000441-199612000-00006
  15. Płudowski P., Karczmarewicz E., Bayer M. et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013; 64 (4): 319–27. DOI: 10.5603/ep.2013.0012
  16. Колоскова А., Воробьева О. Гиповитаминоз D и хроническая боль. Врач. 2018; 29 (9): 31–6 [Koloskova А., Vorobyeva O. Hypovitaminosis D and chronic pain. Vrach. 2018; 29 (9): 31–6 (in Russ.)]. DOI: 10.29296/25877305-2018-09-07
  17. Lopez-Molina M., Santillan C., Murillo M. et al. Measured free 25-hydroxyvitamin D in healthy children and relationship to total 25-hydroxyvitamin D, calculated free 25-hydroxyvitamin D and vitamin D binding protein. Clin Biochem. 2018; 61: 23–7. DOI: 10.1016/j.clinbiochem.2018.08.007
  18. Wallace T.C., Reider C., Fulgoni V.L. 3rd. Calcium and vitamin D disparities are related to gender, age, race, household income level, and weight classification but not vegetarian status in the United States: Analysis of the NHANES 2001-2008 data set. J Am Coll Nutr. 2013; 32 (5): 321–30. DOI: 10.1080/07315724.2013.839905
  19. Moore C.E., Radcliffe J.D., Liu Y. Vitamin D intakes of children differ by race/ethnicity, sex, age, and income in the United States, 2007 to 2010. Nutr Res. 2014; 34 (6): 499–506. DOI: 10.1016/j.nutres.2014.06.002
  20. Струков В.И., Щербакова Ю.Г., Елистратов Д.Г. и др. Факторы риска в ранней диагностике и профилактике остеопороза у детей: обоснование фармакологической коррекции дефицита кальция и витамина D. Врач. 2022; 33 (8): 37–40 [Strukov V., Shcherbakova Yu., Elistratov D. et al. Risk factors in the early diagnosis and prevention of osteoporosis in children: a rationale for pharmacological correction of calcium and vitamin D deficiency. Vrach. 2022; 33 (8): 37–40 (in Russ.)]. DOI: 10.29296/25877305-2022-08-07
  21. Fonseca Santos R.K., Santos C.B., Reis A.R. et al. Role of food fortification with vitamin D and calcium in the bone remodeling process in postmenopausal women: a systematic review of randomized controlled trials. Nutr Rev. 2022; 80 (4): 826–37. DOI: 10.1093/nutrit/nuab055
  22. Aloia J.F., Dhaliwal R., Shieh A. et al. Calcium and vitamin d supplementation in postmenopausal women. J Clin Endocrinol Metab. 2013; 98 (11): E1702–9. DOI: 10.1210/jc.2013-2121
  23. Petrović D., Runjić E., Buljan I. et al. Knowledge and Practice of Pediatricians Regarding Hypovitaminosis D-A Survey across 33 European Countries. Children (Basel). 2022; 9 (12): 1831. DOI: 10.3390/children9121831
  24. Tuyen le D., Hien V.T., Binh P.T. et al. Calcium and Vitamin D Deficiency in Vietnamese: Recommendations for an Intervention Strategy. J Nutr Sci Vitaminol (Tokyo). 2016; 62 (1): 1–5. DOI: 10.3177/jnsv.62.1
  25. Heidari B., Hajian-Tilaki K., Babaei M. Effectiveness and safety of routine calcium supplementation in postmenopausal women. A narrative review. Diabetes Metab Syndr. 2020; 14 (4): 435–42. DOI: 10.1016/j.dsx.2020.04.016
  26. Płudowski P., Kos-Kudła B., Walczak M. et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023; 15 (3): 695. DOI: 10.3390/nu1503069
  27. Ghasemifard N., Hassanzadeh-Rostami Z., Abbasi A. et al. Effects of vitamin D-fortified oil intake versus vitamin D supplementation on vitamin D status and bone turnover factors: A double blind randomized clinical trial. Clin Nutr ESPEN. 2022; 47: 28–35. DOI: 10.1016/j.clnesp.2021.12.025
  28. Braegger C., Campoy C., Colomb V. et al. ESPGHAN Committee on Nutrition. Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr. 2013; 56 (6): 692–701. DOI: 10.1097/MPG.0b013e31828f3c05
  29. Zeng S., Chu C., Doebis C. et al. Reference values for free 25-hydroxy-vitamin D based on established total 25-hydroxy-vitamin D reference values. J Steroid Biochem Mol Biol. 2021; 210: 105877. DOI: 10.1016/j.jsbmb.2021.105877
  30. Sempos C.T., Durazo-Arvizu R.A., Binkley N. et al. Developing vitamin D dietary guidelines and the lack of 25-hydroxyvitamin D assay standardization: The ever-present past. J Steroid Biochem Mol Biol. 2016; 164: 115–9. DOI: 10.1016/j.jsbmb.2015.08.027
  31. Струков В.И., Елистратов Д.Г., Лукьянов В.В. и др. Остеомед Форте – новый эффективный препарат в лечении постменопаузального остеопороза. Академический журнал Западной Сибири. 2012; 6: 6–7 [Strukov V.I., Elistratov D.G., Lukyanov V.V., Katyushina Yu.G. Osteomed Forte is a new effective drug in the treatment of postmenopausal osteoporosis. Akademicheskii zhurnal Zapadnoi Sibiri. 2012; 6: 6–7 (in Russ.)].
  32. Апетов С.С., Калинченко С.Ю. Роль половых гормонов: андрогенов и эстрогенов, в профилактике и терапии остеопороза у мужчин и женщин. Фарматека. 2013; s5–13: 43–5 [Apetov S.S., Kalinchenko S.Yu. The role of sex hormones: androgens and estrogens in the prevention and treatment of osteoporosis in men and women. Farmateka. 2013; s5–13: 43–5 (in Russ.)].
  33. Камилов Ф.Х., Фаршатова Е.Р., Еникеев Д.А. Клеточно-молекулярные механизмы ремоделирования костной ткани и ее регуляция. Фундаментальные исследования. 2014; 7 (4): 836–42 [Kamilov F.Kh., Farshatova E.R., Enikeev D.A. Cellular and molecular mechanisms remodelling of bone tissue and regulation. Fundamental research. 2014; 7 (4): 836–42 (in Russ.)].
  34. Талаева Т.В., Шумаков В.А., Братусь В.В. Coсудистая кальцификация: значимость в патогенезе, диагностике, клиническом течении и прогнозе исходов атеросклероза и ишемической болезни сердца. Український кардіологічний журнал. 2017; 2: 85–98 [Talaeva T.V., Shumakov V.A., Bratus V.V. Vascular calcification: significance in the pathogenesis, diagnosis, clinical course and prognosis of outcomes of atherosclerosis and coronary heart disease. Ukraїns'kii kardіologіchnii zhurnal. 2017; 2: 85–98 (in Russ.)].
  35. Бурмистрова Л.А. Физико-химический анализ и биохимическая оценка биологической активности трутневого расплода. Дисс. … канд. биол. наук. Рязань, 1999; 172 с. [Burmistrova L.A. Physico-chemical analysis and biochemical assessment of the biological activity of the drone brood. Dissertation for the degree of Candidate of Biological Sciences. Ryazan, 1999; 172 p. (in Russ.)].
  36. Струков В.И., Сергеева-Кондраченко М.Ю., Марченкова Л.А. и др. Иммунотерапия постменопаузального остеопороза и других заболеваний костно-суставной системы на фоне гормональной недостаточности. Акушерство и гинекология: новости, мнения, обучение. 2022; 2 (10): 14–22 [Strukov V.I., Sergeeva-Kondrachenko M.Yu., Marchenkova L.A., et al. Immunotherapy of postmenopausal osteoporosis and other diseases of the musculoskeletal system against the background of hormonal deficiency. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie. 2022; 2 (10): 14–22 (in Russ.)]. DOI: 10.33029/2303-9698-2022-10-2-47-55
  37. Струков В.И., Елистратов Д.Г., Сергеева-Кондраченко М.Ю. и др. Остеопороз – способ диагностики и определения эффективности лечения. В сб.: Вопросы безопасности России и постсоветского пространства: история и современность: сб. ст. междунар. науч.-практ. конф. Пенза, 2015; с. 93–100 [Strukov V.I., Elistratov D.G., Sergeeva-Kondrachenko M.Yu. et al. Osteoporosis is a way to diagnose and determine the effectiveness of treatment. Security issues of Russia and the post-Soviet Space: History and Modernity: collection of articles of the International Scientific and Practical conference. Penza, 2015; р. 93–100 (in Russ.)].
  38. Трифонов В., Елистратов Д. Рекомендации по лечению остеопороза в условиях коморбидности и полипрагмазии с помощью препарата «Остеомед Форте» и фитопрепаратов. Врач. 2018; 29 (5): 87–88 [Trifonov V., Elistratov D. Recommendations for the treatment of osteoporosis with the drug «Osteomed Forte» and phytopreparations. Vrach. 2018; 29 (5): 87–88 (in Russ.)].
  39. Марченкова Л.А., Макарова Е.В. Возможности коррекции нарушений кондиционных и координационных двигательных способностей при остеосаркопении с использованием добавки к пище с кальцием и витаминами D3 и В6. Врач. 2020; 31 (7): 61–8. [Marchenkova L.A., Makarova E.V. Possibilities for correction of conditioning and motor coordination problems in osteosarcopenia, by using dietary supplements with calcium and vitamins D3 and B6. Vrach. 2020; 31 (7): 61–8 (in Russ.)]. DOI: 10.29296/25877305-2020-07-12
  40. Юрова О., Марченкова Л. Опыт применения БАД Остеомед Форте в комплексной программе реабилитации пациентов с переломом дистального отдела предплечья на фоне системного остеопороза. Врач. 2020; 31 (2): 47–52 [Yurova O., Marchenkova L. The experience of using of comprehensive rehabilitation program with dietary supplements Osteomed Forte in patients with a osteoporotic distal forearm fracture. Vrach. 2020; 31 (2): 47–52 (in Russ.)]. DOI: 10.29296/25877305-2020-02-11
  41. Марченкова Л.А., Макарова Е.В. Возможности коррекции нарушений кондиционных и координационных двигательных способностей при остеосаркопении с использованием добавки к пище с кальцием и витаминами D3 и В6. Врач. 2020; 31 (7): 61–8 [Marchenkova L.A., Makarova E.V. Possibilities for correction of conditioning and motor coordination problems in osteosarcopenia, by using dietary supplements with calcium and vitamins D3 and B6. Vrach. 2020; 31 (7): 61–8 (in Russ.)]. DOI: 10.29296/25877305-2020-07-12
  42. Кокорева И., Кореньков А., Соловьев И. Влияние препарата Остеомед Форте на сроки консолидации переломов костей у детей и подростков. Врач. 2020; 31 (1): 82–5 [Kokoreva I., Korenkov A., Solovyev I. Effect of Osteomed Forte on the terms of bone fracture consolidation in children and adolescents. Vrach. 2020; 31 (1): 82–5 (in Russ.)]. DOI: 10.29296/25877305-2020-01-18
  43. Купцова Т., Кислов А., Струков В. и др. Остео-вит D3 в лечении детей с повторными переломами костей при остеопорозе. Врач. 2016; 1: 46–7 [Kupczova T., Kislov A., Strukov V. et al. Osteo-Vit D3 in the treatment of children with recurrent bone fractures in osteoporosis. Vrach. 2016; 1: 46–7 (in Russ.)].
  44. Струков В.И., Елистратов Д.Г., Щербакова Ю.Г. и др. Профилактика повторных переломов у детей и подростков с низкой минеральной плотностью костей. Лечащий врач. 2015; 6: 77 [Strukov V.I., Elistratov D.G., Shherbakova Yu.G. et al. Prevention of repeated fractures in children and adolescents with low bone mineral density. Lechashchii vrach. 2015; 6: 77 (in Russ.)].
  45. Струков В., Елистратов Д.Г., Балыкова Л. и др. Переломы костей у детей и подростков – интегральный показатель остеопороза. Врач. 2015; 1: 17–20 [Strukov V., Elistratov D.G., Baly`kova L. et al. Bone fractures in children and adolescents are an integral indicator of osteoporosis. Vrach. 2015; 1: 17–20 (in Russ.)].
  46. Вахрушева Л., Никонорова В., Суворов М. Остеомед Форте в реабилитации детей с детским церебральным параличом. Врач. 2017; 8: 22–4 [Vakhrusheva L., Nikonorova V., Suvorov M. Osteomed Forte in the rehabilitation of children with infantile cerebral palsy. Vrach. 2017; 8: 22–4 (in Russ.)].
  47. Дедов Д.В. Остеопороз у пожилых пациентов: распространенность, патогенез, клиника, профилактика осложнений. Врач. 2021; 32 (7): 82–5. [Dedov D.V. Osteoporosis in elderly patients: prevalence, pathogenesis, clinical presentations, prevention of complications. Vrach. 2021; 32 (7): 82–5 (in Russ.)]. DOI: 10.29296/25877305-2021-07-14